320.86
Penumbra Inc Aktie (PEN) Neueste Nachrichten
MarketBeat cites USD 367.07 average target for Penumbra stock - ad-hoc-news.de
Could STORM-PE Data Change Penumbra (NASDAQ:PEN) Story? - Kalkine Media
Penumbra (PEN) Clinical Data Puts Its Valuation Back In Focus - Yahoo Finance
Penumbra presented STORM-PE data while Penumbra stock trades at EUR 281.30 - AD HOC NEWS
Penumbra (BSP:P2NB34) Total Tax Payable : R$ Mil (As of Jun. 2026) - GuruFocus
Operating cash flow per share of Penumbra, Inc. – HAN:0P8 - TradingView
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism - BioSpace
Penumbra stock gets fresh STORM-PE data catalyst - AD HOC NEWS
Behavioral Patterns of PEN and Institutional Flows - Stock Traders Daily
Penumbra (PEN) Highlights Wearable Device Data Linking Activity to Recovery in Pulmonary Embolism Trial - GuruFocus
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism - PR Newswire
In a lung-clot study, fitness-watch steps lined up with clinic walking tests - Stock Titan
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism - Nasdaq
Penumbra stock reports 14.9 percent revenue growth as EPS misses - AD HOC NEWS
Boston Scientific keeps Penumbra deal on track as Penumbra stock costs EUR 284.00 - AD HOC NEWS
Penumbra, Inc. (PEN) Stock forecasts - Yahoo Finance UK
Revenue per share of Penumbra, Inc. – HAN:0P8 - TradingView
Penumbra stock breaks below 50-day average - AD HOC NEWS
IART vs. PEN: Which Stock Is the Better Value Option? - Zacks Investment Research
Current ratio of Penumbra, Inc. – HAN:0P8 - TradingView
Average basic shares outstanding of Penumbra, Inc. – HAN:0P8 - TradingView
Penumbra, Inc. (PEN) Stock Forecasts - Yahoo Finance
IART or PEN: Which Is the Better Value Stock Right Now? - Zacks Investment Research
The Technical Signals Behind (PEN) That Institutions Follow - news.stocktradersdaily.com
Anaconda Biomed raises $56m for catheter portfolio’s advance - Yahoo Finance
Penumbra, Inc. (PEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Penumbra, Inc. (PEN) Stock Forecasts - Yahoo Finance
ETFs Investing in Penumbra, Inc. Stocks - TradingView
Penumbra Inc. stock trades near 317 dollars as investors weigh growth and valuation - AD HOC NEWS
Penumbra Inc. stock holds near 315 dollars as growth expectations stay high - AD HOC NEWS
Penumbra Stock Price Forecast. Should You Buy PEN? - StockInvest.us
Reasons to Retain Penumbra Stock in Your Portfolio for Now - Yahoo Finance
Reasons to Retain Penumbra Stock in Your Portfolio for Now - Eastern Progress
Penumbra, Inc. (PEN) Stock Analysis: Navigating Growth With A 13.88% Potential Upside - DirectorsTalk Interviews
Price to earnings forward of Penumbra, Inc. – NYSE:PEN - TradingView
Penumbra, Inc. (PEN): Growth Potential Amidst Analyst Consensus And Market Dynamics - directorstalkinterviews.com
Discipline and Rules-Based Execution in PEN Response - Stock Traders Daily
BSP:P2NB34 Enterprise Value: R$-100 Mil | Fairly Valued - GuruFocus
BSP:P2NB34 Shareholder Yield %: 0.05% | Fairly Valued - GuruFocus
BSP:P2NB34 Revenue: R$7,963 Mil | Fairly Valued - GuruFocus
BSP:P2NB34 GF Value: R$57.41 | Fairly Valued - GuruFocus
BSP:P2NB34 ROCE %: 10.74% | Fairly Valued - GuruFocus
Penumbra (BSP:P2NB34) Loans Receivable : R$0 Mil (As of Jun. 2026) - GuruFocus
Penumbra Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
BSP:P2NB34 3-Year EPS without NRI Growth Rate: 188.40% — 5 - GuruFocus
Penumbra (BSP:P2NB34) Land And Improvements : R$0 Mil (As of Jun. 2026) - GuruFocus
Q3 2025 Penumbra Inc Earnings Call Transcript - GuruFocus
BSP:P2NB34 Other Current Assets: R$268 Mil | Fairly Valued - GuruFocus
Penumbra (BSP:P2NB34) Total Long-Term Assets : R$3,231 Mil (As of Jun. 2026) - GuruFocus
BSP:P2NB34 Net Income: R$853 Mil | Fairly Valued - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):